WAT:NYE-Waters Corporation (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 358.36

Change

+11.99 (+3.46)%

Market Cap

USD 10.92B

Volume

0.63M

Analyst Target

USD 210.31
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Waters Corp is an analytical instrument manufacturer. It designs, manufactures, sells and services liquid chromatography, ultra performance liquid chromatography & mass spectrometry instrument systems & support products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+1.46 (+0.77%)

USD 140.35B
A Agilent Technologies Inc

+2.40 (+2.16%)

USD 32.44B
IQV IQVIA Holdings Inc

+2.24 (+1.61%)

USD 24.71B
LH Laboratory Corporation of Amer..

-0.28 (-0.11%)

USD 20.88B
DGX Quest Diagnostics Incorporated

+0.62 (+0.36%)

USD 19.12B
QGEN Qiagen NV

+0.62 (+1.40%)

USD 9.05B
CRL Charles River Laboratories

+1.45 (+1.06%)

USD 6.92B
ENZ Enzo Biochem Inc

+0.01 (+0.85%)

USD 0.02B
MTD Mettler-Toledo International I..

+15.68 (+1.35%)

N/A
TMO Thermo Fisher Scientific Inc

+1.62 (+0.40%)

N/A

ETFs Containing WAT

IVEG iShares Emergent Food and.. 3.24 % 0.00 %

+0.09 (+0.00%)

USD 4.28M
EMEH:PA BNP Paribas Easy Energy &.. 2.67 % 0.00 %

-0.10 (0.00%)

USD 0.08B
GSCU:PA BNP Paribas Easy Energy &.. 2.67 % 0.00 %

-0.10 (0.00%)

USD 0.10B
EMEH:XETRA BNP Paribas Easy Energy &.. 2.67 % 0.00 %

-0.09 (0.00%)

USD 0.11B
GSCE:SW 2.67 % 0.00 %

N/A

N/A
GSCU:SW BNP Paribas Easy Energy &.. 2.67 % 0.00 %

N/A

USD 0.10B
HLTH:AU VanEck Global Healthcare .. 2.49 % 0.00 %

+0.02 (+0.00%)

USD 0.06B
FIW First Trust Water ETF 0.00 % 0.55 %

+0.65 (+0.00%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+2.33 (+0.00%)

USD 5.43B
PHO Invesco Water Resources E.. 0.00 % 0.60 %

+0.29 (+0.00%)

USD 2.04B
PIO Invesco Global Water ETF 0.00 % 0.75 %

-0.03 (0.00%)

USD 0.25B
GSDE:XETRA BNP Paribas Easy Energy &.. 0.00 % 0.00 %

-0.21 (0.00%)

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.40% 83% B 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.40% 75% C 32% F
Trailing 12 Months  
Capital Gain 7.99% 83% B 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.99% 83% B 58% F
Trailing 5 Years  
Capital Gain 81.03% 100% F 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.03% 100% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 11.22% 100% F 74% C
Dividend Return 11.22% 100% F 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 31.27% 33% F 29% F
Risk Adjusted Return 35.88% 92% A 53% F
Market Capitalization 10.92B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.60 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector